Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Aebi

Showing results (11-20 of 78) with videos related to

Pageof 8
Sort By:
Breast (Edinburgh, Scotland)|December 9, 2003
Adjuvant endocrine therapy for the very young patientsStefan Aebi, Monica Castiglione-Gertsch
Breast Disease|October 24, 2009
Infiltrating lobular carcinoma of the breast: systemic treatmentSimone Anna Farese, Stefan Aebi
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 7, 2013
Optimal sequence of tamoxifen and aromatase inhibitors to prevent bone lossKhalil Zaman, Beat Thuerlimann, Stefan Aebi
Praxis|February 4, 2016
[Male Breast Cancer: What is Different?]Philipp Niederberger, Susanne Bucher, Stefan Aebi
Respiration; International Review of Thoracic Diseases|July 10, 2017
A Vexing CA 125 Raise in a Patient with Pleural Effusion and Ovarian CancerSilvia Hofer, Thomas Suter, Stefan Aebi
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 29, 2015
Successful AZD9291 Therapy Based on Circulating T790MOliver Gautschi, Stefan Aebi, Lukas C Heukamp
Breast (Edinburgh, Scotland)|December 21, 2021
Locally advanced breast cancerStefan Aebi, Per Karlsson, Irene L Wapnir
The Lancet. Oncology|October 5, 2007
Controversies of adjuvant endocrine treatment for breast cancer and recommendations of the 2007 St Gallen conferenceManuela Rabaglio, Stefan Aebi, Monica Castiglione-Gertsch
European Journal of Cancer (Oxford, England : 1990)|September 19, 2006
A nurse is a nurse? A systematic review of the effectiveness of specialised nursing in breast cancerManuela R E Eicher, Sara Marquard, Stefan Aebi
BMJ Case Reports|April 9, 2022
Partial response to dabrafenib and trametinib in relapsed BRAF V600E-Mutated multiple myeloma and possible mechanisms of resistanceTina Ernst, Stefan Aebi, Andrea Zander, et al.
Pageof 8

Showing results (11-20 of 78) with videos related to

Sort By:
Pageof 8
Breast (Edinburgh, Scotland)|December 9, 2003
Adjuvant endocrine therapy for the very young patientsStefan Aebi, Monica Castiglione-Gertsch
Breast Disease|October 24, 2009
Infiltrating lobular carcinoma of the breast: systemic treatmentSimone Anna Farese, Stefan Aebi
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 7, 2013
Optimal sequence of tamoxifen and aromatase inhibitors to prevent bone lossKhalil Zaman, Beat Thuerlimann, Stefan Aebi
Praxis|February 4, 2016
[Male Breast Cancer: What is Different?]Philipp Niederberger, Susanne Bucher, Stefan Aebi
Respiration; International Review of Thoracic Diseases|July 10, 2017
A Vexing CA 125 Raise in a Patient with Pleural Effusion and Ovarian CancerSilvia Hofer, Thomas Suter, Stefan Aebi
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 29, 2015
Successful AZD9291 Therapy Based on Circulating T790MOliver Gautschi, Stefan Aebi, Lukas C Heukamp
Breast (Edinburgh, Scotland)|December 21, 2021
Locally advanced breast cancerStefan Aebi, Per Karlsson, Irene L Wapnir
The Lancet. Oncology|October 5, 2007
Controversies of adjuvant endocrine treatment for breast cancer and recommendations of the 2007 St Gallen conferenceManuela Rabaglio, Stefan Aebi, Monica Castiglione-Gertsch
European Journal of Cancer (Oxford, England : 1990)|September 19, 2006
A nurse is a nurse? A systematic review of the effectiveness of specialised nursing in breast cancerManuela R E Eicher, Sara Marquard, Stefan Aebi
BMJ Case Reports|April 9, 2022
Partial response to dabrafenib and trametinib in relapsed BRAF V600E-Mutated multiple myeloma and possible mechanisms of resistanceTina Ernst, Stefan Aebi, Andrea Zander, et al.
Pageof 8